A contractor for the fashion industry has taken to ether claiming that “plus-sizedmodels are going extinct.”
Lynley Eiler’s assertions reflect a significant drop in featured curve models at the New York and London Fashion Weeks over the last three years.
According to model and activist Felicity Haywood, the trend was triggered by showbiz’s favorite weightloss pharmaceutical, Ozempic, in 2023.
Highlights
- Plus-sized model bookings dropped from 70 to just 23 in three years at major fashion weeks.
- Industry insiders cite Ozempic’s popularity as fueling a return to ultra-thin beauty ideals.
- Body positivity advocates warn of shrinking diversity on international runways.
